fda warning letters glp-1 compounding september 2025 compounded Fda Warning Letters Glp-1 Compounded September 2025 There's lots going on this month at FDA FDA Warns Telehealth Firms Over – Rising Costs Lead Insurers to

The increase in letters issued in FY25 is largely due to a surge of unapproved drugs flooding the market, many that were produced by compounders

For a deeper look at safety considerations, visit Is IV vitamin therapy safe

This conclusion is based on the findings from a six-month randomized, double-blinded, placebo-controlled trial involving 54 non-smoking adults who were assigned to receive either a placebo, 250 mg/day of GSH, or 1000 mg/day of GSH

This treatment is effective for a variety of skin concerns that fall under the umbrella of hyperpigmentation, which is simply the medical term for darkened patches of skin